Lucideon will exhibit and present at Making Pharma 2019, which will be held between 30 April and 1 May, at the Ricoh Arena, Coventry, UK.  Lucideon will be exhibiting on stand 327 and presenting a talk titled "Inorganic Abuse Deterrent Carrier for Opioid Drugs".

Lucideon will exhibit at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, held between the 13 and 15th March 2019 in Las Vegas, Nevada, at booth number 5455.

Lucideon is pleased to announce that Agata Lapa is the first to gain a PhD from the cohort of 15 researchers working in the Marie Skłodowska-Curie Innovative Training Network 'Drug-Free Antibacterial Hybrid Biopolymers for Medical Applications – HyMedPoly'.

Lucideon is one of the winners of the Plastics Research and Innovation Fund (PRIF), funded through Innovate UK, the UK's innovation agency.

Lucideon has launched a new materials app designed to provide key materials information at the touch of a button, helping clients find a route to solving their materials and processing challenges.

Lucideon has appointed Lauren Wieties as Healthcare Technical Sales Consultant. Based in Raleigh, USA, Lauren will be joining the team supporting Lucideon’s orthopaedics clients.  

Lucideon is hosting a forum in conjunction with HyMedPoly, a European Union Horizon 2020 funded project, and the Cambridge Network.  The forum will be held on December 14^th at the Entrepreneurship Centre in Cambridge.

Lucideon has appointed Mick Tait as Pharmaceutical Quality Manager.  Mick will be responsible for maintaining compliance of the Pharmaceutical Chemistry and Pharmaceutical Microbiology divisions to EU Good Manufacturing Practice (GMP) Guidelines.

Lucideon has added nanoparticle analysis to its suite of analytical capabilities with the purchase of a LitSizer 500, manufactured by Anton Paar.  The LitSizer is capable of measuring particles in the range of 1-1000nm and allows Lucideon to offer analysis and consultancy to manufacturers and development teams working with nanoparticles across a wide range of sectors.

Lucideon has appointed a new figurehead to lead the company's strategic growth in the global advanced materials marketplace. 

Lucideon is gearing up for growth with a significant investment in staff, systems, facilities and ventures into new markets.

Lucideon is pleased to announce that it will be exhibiting at this year’s Ceramics Expo in Ohio, 1-3 May.  In addition to showcasing its ceramics technologies, and materials, product and process support capabilities, two members of the team will be presenting at the conference.

Lucideon is holding its 4^th, free to attend, Innovations for Industry event ‘Advancing Formulations - Oral, Skin & Hair Care’ on Wednesday 13 June 2018 at its headquarters in Stoke-on-Trent, Staffordshire.

Lucideon has released a new white paper titled ‘Cleaning and Sterilization Validation of Reusable Medical Devices’.

Lucideon is exhibiting at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, held between the 6-10th March 2018, exhibition stand no. 4221.

Lucideon has had an article on abuse deterrent formulations (ADFs), ‘The Prescription Abuse Epidemic: Designing a Solution’, published in ONdrugDelivery, the specialist drug delivery publication.

Lucideon has invested in a new white light interferometer (WLI) to increase its analytical support for wear testing clients in the US, and other applications.

Lucideon has welcomed five researchers from the Institute of Biomaterials, Friedrich Alexander University Erlangen – Nuremberg, Germany to its headquarters in Stoke-on-Trent, UK to develop new anti-bacterial materials.

Lucideon has extended its mechanical testing services to include testing of micro materials, through the development of new, customized test methods.

Lucideon is presenting at the 6th China-Europe Symposium on Biomaterials in Regenerative Medicine on ‘Advanced Materials for Biomedical Applications’ with a specific focus on hard tissue materials innovation.